Wan‐Lun Hsu

1.9k total citations
59 papers, 1.1k citations indexed

About

Wan‐Lun Hsu is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Wan‐Lun Hsu has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 22 papers in Otorhinolaryngology and 18 papers in Surgery. Recurrent topics in Wan‐Lun Hsu's work include Head and Neck Cancer Studies (22 papers), Viral-associated cancers and disorders (21 papers) and Polyomavirus and related diseases (11 papers). Wan‐Lun Hsu is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Viral-associated cancers and disorders (21 papers) and Polyomavirus and related diseases (11 papers). Wan‐Lun Hsu collaborates with scholars based in Taiwan, United States and Australia. Wan‐Lun Hsu's co-authors include Li‐Jen Liao, Wu‐Chia Lo, Cheng‐Ping Wang, Chi‐Te Wang, Mei‐Shu Lai, Kelly J. Yu, Allan Hildesheim, Pei‐Jen Lou, Tseng‐Cheng Chen and Chien‐Jen Chen and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer.

In The Last Decade

Wan‐Lun Hsu

52 papers receiving 1.1k citations

Peers

Wan‐Lun Hsu
Ellie Maghami United States
Amy B. W. Chan Hong Kong
Zahra Maleki United States
Kaveh Zakeri United States
Lydia Fresco United Kingdom
Mahesh Kudrimoti United States
Ellie Maghami United States
Wan‐Lun Hsu
Citations per year, relative to Wan‐Lun Hsu Wan‐Lun Hsu (= 1×) peers Ellie Maghami

Countries citing papers authored by Wan‐Lun Hsu

Since Specialization
Citations

This map shows the geographic impact of Wan‐Lun Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Lun Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Lun Hsu more than expected).

Fields of papers citing papers by Wan‐Lun Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Lun Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Lun Hsu. The network helps show where Wan‐Lun Hsu may publish in the future.

Co-authorship network of co-authors of Wan‐Lun Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Lun Hsu. A scholar is included among the top collaborators of Wan‐Lun Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Lun Hsu. Wan‐Lun Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Tram Kim, Yi‐Ting Chen, Wan‐Lun Hsu, et al.. (2025). Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort study. Hepatology. 83(2). 261–275.
2.
Jackson, Sarah S., Julia M. Francis, Ruth M. Pfeiffer, et al.. (2025). Sex Differences in Anti–Epstein-Barr Virus Antibody Responses. The Journal of Infectious Diseases. 232(4). e671–e675. 2 indexed citations
3.
Hsu, Wan‐Lun, Jun Tao, Kelly J. Yu, et al.. (2024). Kinetics of EBV antibody‐based NPC risk scores in Taiwan NPC multiplex families. International Journal of Cancer. 155(8). 1400–1408.
4.
Chen, Yong‐Chen, et al.. (2024). Active Surveillance in Early Thyroid Cancer: A Meta-Analysis. Diagnostics. 14(23). 2628–2628.
5.
Chung, Chen‐Shuan, Chia‐Yun Wu, Wu‐Chia Lo, et al.. (2024). Screening and surveillance of esophageal cancer by magnifying endoscopy with narrow band imaging improves the survival of hypopharyngeal cancer patients. Frontiers in Oncology. 13. 1221616–1221616. 3 indexed citations
6.
Liao, Li‐Jen, Wan‐Lun Hsu, Chi‐Ju Chen, & Yen‐Ling Chiu. (2023). Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma. Biomedicines. 11(6). 1528–1528. 4 indexed citations
7.
Hsu, Wan‐Lun, Chun‐Ju Chiang, Ya‐Wen Yang, et al.. (2023). Trends and sex‐specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer Medicine. 12(14). 15350–15357. 9 indexed citations
9.
Lin, Ping‐Yi, Ping‐Chia Cheng, Wan‐Lun Hsu, et al.. (2022). Risk of CVD Following Radiotherapy for Head and Neck Cancer: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology. 12. 820808–820808. 10 indexed citations
10.
Wu, Chia‐Yun, Yu‐Hsuan Lin, Wu‐Chia Lo, et al.. (2022). Nutritional status at diagnosis is prognostic for pharyngeal cancer patients: a retrospective study. European Archives of Oto-Rhino-Laryngology. 279(7). 3671–3678. 24 indexed citations
11.
Yu, Kelly J., Wan‐Lun Hsu, Chun‐Ju Chiang, et al.. (2021). Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years. Cancer. 127(22). 4171–4176. 3 indexed citations
12.
Simon, Julia, Zhiwei Liu, Nicole Brenner, et al.. (2020). Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology. Journal of Clinical Microbiology. 58(5). 13 indexed citations
13.
Fang, Kai‐Min, et al.. (2019). Ultrasonographic and elastographic biometry in adult major salivary glands: a preliminary case-control report. Scientific Reports. 9(1). 8885–8885. 8 indexed citations
14.
Coghill, Anna E., Ruth M. Pfeiffer, Carla Proietti, et al.. (2018). Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clinical Cancer Research. 24(6). 1305–1314. 47 indexed citations
15.
Liao, Li‐Jen, Wu‐Chia Lo, Wan‐Lun Hsu, Po‐Wen Cheng, & Cheng‐Ping Wang. (2017). Assessment of pain score and specimen adequacy for ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. Journal of Pain Research. Volume 11. 61–66. 9 indexed citations
16.
Coghill, Anna E., Wei Bu, Hanh Nguyen, et al.. (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clinical Cancer Research. 22(14). 3451–3457. 32 indexed citations
17.
Lee, Yi‐Chia, Ping‐Huei Tseng, Tseng‐Cheng Chen, et al.. (2016). Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy. Oral Oncology. 55. 55–60. 27 indexed citations
18.
Coghill, Anna E., Wan‐Lun Hsu, Ruth M. Pfeiffer, et al.. (2014). Epstein–Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1213–1219. 52 indexed citations
19.
Liao, Li‐Jen, Wu‐Chia Lo, Wan‐Lun Hsu, Chi‐Te Wang, & Mei‐Shu Lai. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities. BMC Cancer. 12(1). 236–236. 164 indexed citations
20.
Yu, Kelly J., Wan‐Lun Hsu, Chun‐Ju Chiang, et al.. (2008). Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. International Journal of Cancer. 124(7). 1622–1625. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026